Herbert Virgin - Aug 23, 2021 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role: EVP, Research & CSO
Signature: /s/ Howard Horn, Attorney-in-Fact
Stock symbol: VIR
Transactions as of: Aug 23, 2021
Transactions value $: -$666,463
Form type: 4
Date filed: 8/24/2021, 06:44 PM
Previous filing: Aug 11, 2021
Next filing: Aug 25, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIR	Common Stock	Options Exercise	$21K	+13.8K	+13.79%	$1.53^*	113K	Aug 23, 2021	Direct
transaction	VIR	Common Stock	Sale	-$688K	-13.8K	-12.12%	$50.00	99.7K	Aug 23, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VIR	Stock Option (Right to Buy)	Options Exercise	$0	-13.8K	-4.82%	$0.00	272K	Aug 23, 2021	Common Stock	13.8K	$1.53	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.
F2	1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.